Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 158 results found. Search for [ Oxford vaccine trial stage ]

Results 1 to 21 of 158
PTI
April 4, 2021
The pilot schemes involving what is being dubbed as 'Covid-status certification' will include the football FA Cup final at Wembley Stadium in London and are expected to involve a smartphone app or a paper certificate


Reuters
March 13, 2021
Novavax is also developing new formulations of its vaccine to protect against emerging variants and plans to initiate clinical testing of these shots in the second quarter of this year


Reuters
March 4, 2021
Government data shows that only 10% of about 12.6 million people immunised in India have taken the COVAXIN shot, which was found to be 81% effective in an interim analysis of the late-stage trial, its developer Bharat Biotech said


PB Jayakumar
March 3, 2021
So far, the Pfizer-BioNTtech and Moderna vaccines, made through a novel platform technology never used in humans before, are proven to have maximum efficacy


Reuters
February 25, 2021
India has vaccinated more than 10.5 million health and front-line workers since beginning its immunisation campaign on January 16


BusinessToday.In
February 24, 2021
Biological E has tied up with vaccine maker Johnson & Johnson and Baylor College of Medicine in Houston. And, it plans to start the Phase 3 trial of the candidate licensed from Baylor College next week


Reuters
February 12, 2021
In India, we are fortunate that supply of vaccines is not a rate-limiting step, but to meet the timelines set by the government, we will have to immunise somewhere between 4 and 5 times more people each day than we are doing today, says Gagandeep Kang of Christian Medical College in Vellore


BusinessToday.In
February 12, 2021
Chhattisgarh CM had raised two primary concerns regarding Covaxin -- inhibitions on incomplete trials and absence of \"expiration date\". Dr Vardhan says vaccine approved after due evaluation of pre-clinical and clinical trial data and that expiry date is mentioned on its label


BusinessToday.In
New Delhi, February 2, 2021
Industry leaders praised the steps to provide tax relief to senior citizens, encourage expenditure for infrastructure development and emphasis on healthcare in Union Budget 2021-22; Farmer unions have announced a nationwide 'chakka jam' on February 6 against the internet ban on their agitation spots and alleged harassment by the authorities; About 1,500 of the initial volunteers in a late-stage clinical trial of the Oxford/AstraZeneca Covid-19 vaccine received wrong dose. Watch this and more on News Blast.Also Read: Sensex reclaims 50,000 mark, Nifty crosses 14,700 after investors cheer Budget 2021


Reuters
February 2, 2021
The firm obtained rights to supply the AZD1222 vaccine, developed by the Anglo-Swedish drugmaker and Oxford University, in mainland China last year in return for having capacity to produce at least 200 million doses by the end of 2021


Rashi Bisaria
New Delhi, February 2, 2021
Budget 2021: India Inc welcomes tax relief, infra spend fillip Finance Minister's third Budget speech managed to enthuse Indian corporate sector. Industry leaders praised the steps to provide tax relief to senior citizens, encourage expenditure for infrastructure development and emphasis on healthcare in Union Budget 2021-22. Uday Kotak, the Executive Vice Chairman and Managing Director of Kotak Mahindra Bank, hailed the focus on healthcare, infrastructure and financial sectors. Stainless...


Reuters
February 2, 2021
The dosing mishap was presented to the trial participants in a letter dated June 8 as an opportunity for University of Oxford researchers to learn how well the vaccine works at different doses


Reuters
January 21, 2021
If allowed to go ahead, this would be the first trial of any coronavirus vaccine in Bangladesh and could give the densely-populated country of more than 160 million faster access to the shot for mass use


Reuters
January 14, 2021
As of now, the pre-condition for any vaccine to be implemented in India is that you have to do a bridging trial, said Niti Aayog member VK Paul who also heads National Expert Group On Vaccine Administration for COVID-19 (NEGVAC)


PTI
January 6, 2021
(For) all our vaccines, we are looking at right now..(we) are targeting 2-8 degree because our logistics are worked out on that basis and we are working on that, DBT secretary Renu Swarup said at a press briefing


BusinessToday.In
December 29, 2020
The chief executive of Serum Institute - the biggest vaccine maker in the world by volume - said all trial data for Covishield has been provided to authorities in the UK and India as \"nobody wants to risk safety\"


Reuters
December 18, 2020
The university said it had explored two dosing regimes in early stage trials, a full-dose/full-dose regime and a full-dose/half-dose regime, investigated as a possible 'dose sparing' strategy


PTI
December 16, 2020
The applications are being examined on scientific basis, using the frameworks that are scientific, frameworks that are globally aligned and ensuring that the vaccine is safe, NITI Aayog member (health) Dr V K Paul said


PB Jayakumar
December 11, 2020
As the country plans to vaccinate 30 crore people by July in the first phase, it may be difficult to bank alone on the Indian vaccines, especially Serum Institute's (SII) Covishield


BusinessToday.In
December 9, 2020
AstraZeneca is currently seeking regulatory approval in many countries across the world. The company hopes that it will get the approval of MHRA, UK's regulator, within the next few weeks


PAGES 1 OF 8  12345